While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
Catalog #: SHCTL-LUC-PRSIT17
$300.00
Tet-inducible shRNA targeting the luciferase protein in a standard lentiviral construct. The U6 promoter driving shRNA expression is responsive to the tetracycline analog doxocycline. Typically used as a negative control for RNAi studies, but can be used to knockdown luciferase in cells engineered to express the targeted luciferase variation.